SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction BEIJING, March 27, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that on March 26, 2018, it entered]